K143072 is an FDA 510(k) clearance for the ENROUTE Transcarotid Neuroprotection System. Classified as Temporary Carotid Catheter For Embolic Capture (product code NTE), Class II - Special Controls.
Submitted by Silk Road Medical, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on February 9, 2015 after a review of 105 days - within the typical 510(k) review window.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.
View all Silk Road Medical, Inc. devices
NCT01685567
Completed
Interventional
Industry-sponsored
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter.
| Condition studied |
Carotid Artery Disease |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Christopher Kwolek, MD |
| Sponsor |
Silk Road Medical
(industry)
|
Started 2012-11-01
→
Primary completion 2016-03-01
→
Completed 2016-07-01
Primary outcome
Hierarchical Composite of Stroke, Myocardial Infarction, and Death
Secondary outcome
All Death (Non-hierarchical)
View full study on ClinicalTrials.gov